Evidence map›Paper›PMID 38212312›Full record

ArticleNature communications2024

Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila.

Daewon Lee, Eunju Yoon, Su Jin Ham, Kunwoo Lee, Hansaem Jang, Daihn Woo, Da Hyun Lee, Sehyeon Kim, Sekyu Choi, Jongkyeong Chung

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The relevance of combined testing of cerebrospinal fluid glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in multiple sclerosis and peripheral neuropathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Daewon Lee *Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0003-0271-1108
Eunju Yoon *Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0003-3009-8144
Su Jin Ham *Institute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea.
Kunwoo LeeSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea.ORCID 0009-0001-6958-3684
Hansaem JangDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea.ORCID 0000-0001-7258-4795
Daihn WooInstitute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0001-8116-4936
Da Hyun LeeInstitute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0003-0985-9092
Sehyeon KimInstitute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea.ORCID 0000-0002-5737-210X
Sekyu ChoiSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea. sekyuchoi@postech.ac.kr.ORCID 0000-0003-2928-0942
Jongkyeong ChungInstitute of Molecular Biology and Genetics, Seoul National University, Seoul, 08826, Republic of Korea. jkc@snu.ac.kr.ORCID 0000-0001-5894-7537
Seoul National University · KRPohang University of Science and Technology · KR

Funding

National Research Foundation of Korea (NRF) NRF-2020R1A5A1018081National Research Foundation of Korea (NRF) NRF-2021R1A2C1010577National Research Foundation of Korea (NRF) NRF-2022R1A6A3A01085862National Research Foundation of Korea (NRF) NRF-2022R1C1C1011895National Research Foundation of Korea (NRF) RS-2023-00211029
6 · The paper itself

Abstract

Diabetic sensory neuropathy (DSN) is one of the most common complications of type 2 diabetes (T2D), however the molecular mechanistic association between T2D and DSN remains elusive. Here we identify ubiquitin C-terminal hydrolase L1 (UCHL1), a deubiquitinase highly expressed in neurons, as a key molecule underlying T2D and DSN. Genetic ablation of UCHL1 leads to neuronal insulin resistance and T2D-related symptoms in Drosophila. Furthermore, loss of UCHL1 induces DSN-like phenotypes, including numbness to external noxious stimuli and axonal degeneration of sensory neurons in flies' legs. Conversely, UCHL1 overexpression improves DSN-like defects of T2D model flies. UCHL1 governs insulin signaling by deubiquitinating insulin receptor substrate 1 (IRS1) and antagonizes an E3 ligase of IRS1, Cullin 1 (CUL1). Consistent with these results, genetic and pharmacological suppression of CUL1 activity rescues T2D- and DSN-associated phenotypes. Therefore, our findings suggest a complete set of genetic factors explaining T2D and DSN, together with potential remedies for the diseases.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistanceAnimalsDrosophilaNeuronsUbiquitin ThiolesteraseUbiquitin Thiolesterase

Identifiers

PMID38212312
PMCPMC10784524
OpenAlexW4390753551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.